About Longevous BeamtechFor the Health of People
Established in February 2017, Sichuan Longevous Beamtech Co., Ltd. is a high-tech enterprise integrating R&D, production and customer service of high-end nuclear medical equipment. Longevous Beamtech is committed to becoming a global solution provider for radiopharmaceuticals.
Since its establishment, Longevous Beamtech has been concentrating on the field of nuclear medical equipment. From R&D, production to solution design, after-sales technical support, we always focus on customer needs, providing full lifecycle services.Up to now, the company has obtained numerous authoritative certifications such as ISO Certifications and over 100 cyclotron-related patents, with business covering several countries and regions around the world.
-
Vision
• For the health of people
-
Missions
• Provide reliable nuclear medical equipment and solutions for customers
• Bring returns for investors
• Create value for society
• Contribute to national health -
Values
• Innovation
• Collaboration
• Service
• Precision
Verified Custom manufacturer
100% Factory by Longevous Beamtech
18+
Production and Research Experience
60+
Cyclotron-Related Patents
30%
China Market Share
40+
Over 40 Units Await Delivery Worldwide
100%
Independent Intellectual Property Rights
100000+
No.of Patients Served
R&D Capability
01Quality Assurance
· World-leading production capacity, capable of producing 100 units (sets) annually.
· Capable of rapid delivery, requiring only 6 months from order to delivery.
· Comprehensive radiopharmaceutical solutions, providing one-stop project planning, construction, and operation.
Mature Application
· Multiple systems sold globally, successfully entering international markets including Asia, Africa, and Latin America.
· Products have been widely installed and used in clinical applications, with performance fully validated.
Production Capacity
01Technology Driven
· Originating from technology transfer and achievements of the China Academy of Engineering Physics.
· Possesses core algorithms for accelerator development with completely independent intellectual property rights; product localization rate exceeds 99%.
Sustained Innovation
· A top-tier, interdisciplinary Ph.D. team synergizes with cutting-edge technology platforms and an open ecosystem, enabling rapid breakthroughs and iteration in key technologies.
· Masters core technologies for the entire chain of equipment for the production, purification, and pharmaceutical synthesis of various key isotopes; production yields are industry-leading.
CE
CE
ISO9001
ISO13485
01020304
2007-2013
• Completed the physical design and prototype of cyclotron
• Achieved localization of key components
2013-2016
• Developed the engineering prototype of the cyclotron
• Significantly improved overall performance
2016-2017
• Established Longevous Beamtech Co.,Ltd
• Officially launched the 11MeV commercial machine
• Initiated the development of a series of energy spectrum products
• Successfully synthesized FDG drugs
2017-2019
• Advanced the R&D of 7MeV and 20MeV models
• Stabilized production processes and established a pilot production line
• Signed the first commercial contract
2019-2021
• Installed the first cyclotron in hospital
• Trial production of LB-7 and LB-20 models
• Initiated R&D of the 30MeV model
• Started construction of the Phase I production and R&D base
2022-2025
• Successfully launched LB-7 and LB-20 models
• Initiated R&D of the synthesis module
• Phase I production and R&D base put into operation
• Completed R&D of the core equipment for the 30MeV model
• Achieved a market share of 30%
• Signed the first overseas contract
010203040506